Orthofix reported net sales of $144.7 million for the third quarter of 2011, representing a 4 percent increase over the third quarter of 2010, according to an Orthofix news release (pdf).
The company's revenues from strategic projects were also up by 5 percent. The company experienced a 31 percent decrease in divested products and a 1 percent decrease in spinal products. The largest growth segment was orthopedics, which experienced a 16 percent increase over last year, followed by sports medicine, which experienced an 8 percent increase.
The success in orthopedics sales was driven by an increase in procedures using the company's Trinity Evolution knee implant.
Related Articles on Orthopedic Device Companies:
Spineology to Unveil Threshold Pedicular Fixation System
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer
The success in orthopedics sales was driven by an increase in procedures using the company's Trinity Evolution knee implant.
Related Articles on Orthopedic Device Companies:
Spineology to Unveil Threshold Pedicular Fixation System
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer